Skip to main content
. 2001 Jul;159(1):313–320. doi: 10.1016/S0002-9440(10)61697-5

Figure 3.

Figure 3.

Intravascular injection of Av3nBg results in high levels of β-galactosidase activity in the liver and levels in the eye that are not greater than background. Five days after intravascular injection of 2 × 10 11 particles, mice were sacrificed and the liver and eyes were rapidly removed and β-galactosidase activity was measured in liver and eye homogenates. β-galactosidase activity was three orders of magnitude higher in the liver than in the eye where it was the same as that in eyes not injected with Av3nBg.